Institue For Molecular Medicine Inc entered the industry of Medical Research in 1999 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Nancy Nicolson by calling (714) 596-7821 during business hours. You can also write to the business’ Single Location at 16371 Gothard St # H, Huntington Beach, California CA 92647. You can also visit the company’s website at immed.org. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Institue For Molecular Medicine Inc |
Representative: | Nancy Nicolson |
Place of Business: | 16371 Gothard St # H, Huntington Beach, CA 92647 |
Contact Number: | (714) 596-7821 |
Website: | immed.org |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 541720 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1999 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Institue For Molecular Medicine Inc is a company operating from Orange, California providing professional Medical Research and relevant B2B variables. It was founded in 1999 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Institue For Molecular Medicine Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Nancy Nicolson at (714) 596-7821 for related queries, or to locate its Single Location using the coordinates 33.722984,-118.000307.
The Single Location can also be found at the street address 16371 Gothard St # H in Huntington Beach, California 92647 and can be engaged online through the company website at immed.org, the company Twitter , and Facebook page .